Literature DB >> 6576988

Mucormycosis in the immunocompromised host.

S Bhaduri, E Kurrle, E Vanek, R Spanel.   

Abstract

We are presenting two typical case histories of mucormycosis in patients with acute leukaemia which illustrate some of the important features of this infection in compromised hosts. In such patients, mucormycosis is mostly pulmonary or widely disseminated and often has a rapidly fatal course. A microbiological diagnosis from blood or sputum is difficult to establish. Mucormycosis or other fungal infections should be suspected in compromised patients with infections which do not respond to adequate antibiotic therapy.

Entities:  

Mesh:

Year:  1983        PMID: 6576988     DOI: 10.1007/bf01641299

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Mucormycosis; a new disease?

Authors:  R D BAKER
Journal:  J Am Med Assoc       Date:  1957-03-09

Review 2.  Mucormycosis-changing status.

Authors:  R D Meyer; D Armstrong
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1973-12

3.  Phycomycosis complicating leukemia and lymphoma.

Authors:  R D Meyer; P Rosen; D Armstrong
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

Review 4.  Opportunistic fungal infections in patients with neoplastic diseases.

Authors:  P P Rosen
Journal:  Pathol Annu       Date:  1976

Review 5.  Opportunistic invasive fungal infections in patients with leukaemia lymphoma.

Authors:  J A Krick; J S Remington
Journal:  Clin Haematol       Date:  1976-06

6.  Pulmonary mucormycosis.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1972-01-13       Impact factor: 91.245

7.  Effective treatment for rhinopulmonary mucormycosis in a boy with leukaemia.

Authors:  O B Eden; J Santos
Journal:  Arch Dis Child       Date:  1979-07       Impact factor: 3.791

8.  The changing spectrum of disease, etiology, and diagnosis of mucormycosis.

Authors:  A M Marchevsky; E J Bottone; S A Geller; D K Giger
Journal:  Hum Pathol       Date:  1980-09       Impact factor: 3.466

  8 in total
  5 in total

Review 1.  Systemic zygomycosis.

Authors:  E W Benbow; R W Stoddart
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

2.  Mucormycosis and ameloblastoma of the upper jaw.

Authors:  X Molero; J Canals; A Rilo; A Ortega
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

3.  Reduction of infection frequency by intravenous gammaglobulins during intensive induction therapy for small cell carcinoma of the lung.

Authors:  R E Schmidt; J H Hartlapp; D Niese; H J Illiger; I Stroehmann
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

Review 4.  Opportunistic zygomycotic infections. A literature review.

Authors:  A Espinel-Ingroff; L A Oakley; T M Kerkering
Journal:  Mycopathologia       Date:  1987-01       Impact factor: 2.574

5.  Myocardial infarction caused by cardiac disease in disseminated zygomycosis.

Authors:  E W Benbow; R F McMahon
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.